ConductScience.org, home

Paper218151

Estrogen replacement therapy I: a 10-year prospective study in the relationship to osteoporosis.

Nachtigall LE and 3 others. Obstet Gynecol, 1979. Cited by 363 papers, by iCite.

Cite this record

ConductScience Library. Estrogen replacement therapy I: a 10-year prospective study in the relationship to osteoporosis. Papers, record 218151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/218151

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Estrogen replacement therapy I: a 10-year prospective study in the relationship to osteoporosis.
PubMed
Journal
Obstet Gynecol
PubMed
Year
1979
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
363
iCite
Relative citation ratio, by iCite
16
iCite
Revised in PubMed
2013-11-21
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nachtigall LEL E
2Nachtigall RHR H
3Nachtigall RDR D
4Beckman EME M

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Estrogens, Conjugated (USP)Major topic
MedroxyprogesteroneMajor topic
MenopauseMajor topic
OsteoporosisMajor topic
Clinical Trials as Topic
Double-Blind Method
Female
Humans
Prospective Studies
Time Factors

Source PubMed

Download CSV of topics

Cited by60

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 363 citations.

PMIDTitleJournalYearIn PapersSource
35409368Sex Differences in Cardiovascular Diseases: A Matter of Estrogens, Ceramides, and Sphingosine 1-Phosphate.Int J Mol Sci2022https://conductscience.org/library/papers/35409368PubMed
30216118A heartfelt message, estrogen replacement therapy: use it or lose it.Am J Physiol Heart Circ Physiol2018https://conductscience.org/library/papers/30216118PubMed
27322315Osteoporosis: Modern Paradigms for Last Century's Bones.Nutrients2016https://conductscience.org/library/papers/27322315PubMed
24910928Menopausal hormone therapy and cancer: changing clinical observations of target site specificity.Steroids2014https://conductscience.org/library/papers/24910928PubMed
23315354Pharmacokinetics of estradiol valerate 2mg + dienogest 2mg (climodien® 2/2) after single and repeated oral administration in healthy postmenopausal women.Clin Drug Investig2000https://conductscience.org/library/papers/23315354PubMed
22427684Changing concepts: Menopausal hormone therapy and breast cancer.J Natl Cancer Inst2012https://conductscience.org/library/papers/22427684PubMed
21267140Estrogen replacement therapy for postmenopausal osteoporosis.Can Fam Physician1986https://conductscience.org/library/papers/21267140PubMed
21153101Salmon calcitonin nasal spray : An effective alternative to estrogen therapy in select postmenopausal women.Endocrine1996https://conductscience.org/library/papers/21153101PubMed
20469458A rationale for the current management of post-menopausal osteoporosis.Can Fam Physician1986https://conductscience.org/library/papers/20469458PubMed
16626523Canadian Consensus Conference on osteoporosis, 2006 update.J Obstet Gynaecol Can2006https://conductscience.org/library/papers/16626523PubMed
15542889Hormones and bone health in postmenopausal women.Endocrine2004https://conductscience.org/library/papers/15542889PubMed
14534773Predicting the effects of estrogen replacement therapy on lumbar bone mineral density in oophorectomized women: analysis of a 10-year longitudinal study.Osteoporos Int2003https://conductscience.org/library/papers/14534773PubMed
11788576Guidelines on the management of osteoporosis associated with chronic liver disease.Gut2002https://conductscience.org/library/papers/11788576PubMed
11465306Hip fracture prevention: cost-effective strategies.Pharmacoeconomics2001https://conductscience.org/library/papers/11465306PubMed
11087009Preventing fractures in postmenopausal women with osteoporosis. A review of recent controlled trials of antiresorptive agents.Drugs Aging2000https://conductscience.org/library/papers/11087009PubMed
10150160Translating safety, efficacy and compliance into economic value for controlled release dosage forms.Pharmacoeconomics1994https://conductscience.org/library/papers/10150160PubMed
9225138Use of estrogen for prevention and treatment of osteoporosis.Endocrine1997https://conductscience.org/library/papers/9225138PubMed
9205638Hormone replacement therapy in the prevention and treatment of osteoporosis.Osteoporos Int1997https://conductscience.org/library/papers/9205638PubMed
8873639Clinical practice guidelines for the diagnosis and management of osteoporosis. Scientific Advisory Board, Osteoporosis Society of Canada.CMAJ1996https://conductscience.org/library/papers/8873639PubMed
8800784Changes in bone density in women starting hormone replacement therapy compared with those in women already established on hormone replacement therapy.Osteoporos Int1995https://conductscience.org/library/papers/8800784PubMed

See all 60 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/218151

GET https://conductscience.org/api/papers/v1/218151/cited_by?page=2